• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q180V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pancreatitis (4481)
Event Date 03/29/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "endoscopic ultrasound plus endoscopic retrograde cholangiopancreatography based tissue sampling for diagnosis of proximal and distal biliary stenosis due to cholangiocarcinoma: results from a retrospective single-center study." abstract: differentiating between benign and malignant biliary stenosis (bs) is challenging, where tissue diagnosis plays a crucial role.Endoscopic retrograde cholangiopancreatography (ercp)- based tissue sampling and endoscopic ultrasound (eus) with fine-needle aspiration (fna) or biopsy (fnb) are used to obtain tissue specimens from bs.The aim of this retrospective study was to evaluate the diagnostic yield of eus-fna/b plus ercp with brushing or forceps biopsy in bs.All endoscopic procedures performed in patients with bs at our gastroenterology unit were reviewed.The gold standard for diagnosis was histopathology of surgical specimens or the progression of the malignancy at radiological or clinical follow-up.A total of 70 endoscopic procedures were performed in 51 patients with bs.Final endoscopic diagnosis was reached in 96% of the patients and was malignant in 61.7% and benign in 38.3% of cases.Sensitivity, specificity, and diagnostic accuracy were 73.9%, 100%, and 80%, respectively, for eus-fna/b; 66.7%, 100%, and 82.5% for ercp; and 83.3%, 100%, and 87.5% for both procedures carried out in the same session.The combination of eus and ercp tissue sampling seems to increase diagnostic accuracy in defining the etiology of bs.Performing both procedures in a single session reduces the time required for diagnostic work-up and optimizes resources.This article includes 3 olympus devices and the reported adverse events: (b)(6): tjf-q180v, the literature described "tjf-180", we selected "tjf-q180v" as a representative product.(b)(6): fb-26n-1.(b)(6): gf-uct180.Mild post-ercp bleeding -(1) mild post-ercp pancreatitis -(1) this report is 1 of 3 for (b)(6): tjf-q180v, the literature described "tjf-180", we selected "tjf-q180v" as a representative product.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key14218886
MDR Text Key290160793
Report Number8010047-2022-07102
Device Sequence Number1
Product Code FDT
UDI-Device Identifier04953170339967
UDI-Public04953170339967
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K143153
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-Q180V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/31/2022
Initial Date FDA Received04/27/2022
Supplement Dates Manufacturer Received05/24/2022
Supplement Dates FDA Received06/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNKNOWN SERIALS: FB-26N-1, GF-UCT180
Patient Outcome(s) Other;
-
-